Addressing alcohol use among blood pressure patients in Thai primary care: Lessons from a survey-based stakeholder consultation.

Alcohol use Hypertension Lifestyle intervention Primary Health Care Screening and brief intervention Stakeholder survey Thailand

Journal

Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 07 02 2022
revised: 12 08 2022
accepted: 14 08 2022
entrez: 26 9 2022
pubmed: 27 9 2022
medline: 27 9 2022
Statut: epublish

Résumé

Alcohol use is a major risk factor for noncommunicable diseases in Thailand, and one of its pathways is high blood pressure. Given that brief intervention can effectively reduce hazardous alcohol consumption, this study aimed to investigate how hypertensive patients with concomitant alcohol use are identified and treated in Thai primary care settings and what this may mean for screening and lifestyle intervention strategies. In a cross-sectional, mixed-method design, we surveyed 91 participants from three different groups of Thai stakeholders: policy- and decisionmakers; healthcare practitioners; and patients diagnosed with hypertension. Data was collected between December 2020 and May 2021. Responses were analyzed descriptively and using open coding tools to identify current practices, barriers, facilitators, and implications for interventions. All stakeholder groups regarded alcohol use as an important driver of hypertension. While lifestyle interventions among hypertensive patients were perceived as beneficial, current lifestyle support was limited. Barriers included limited resources in primary healthcare facilities, lack of continuous monitoring or follow-up, missing tools or procedures for risk assessment and lifestyle intervention, and stigmatization of alcohol use. Our results suggest that although screening for lifestyle risk factors (including alcohol use) and lifestyle interventions are not yet sufficiently established, a wide range of stakeholders still recognize the potential of interventions targeted at hazardous alcohol use among hypertensive patients. Future interventions may establish standardized assessment tools, be tailored to high-risk groups, and include electronic or remote elements.

Identifiants

pubmed: 36161118
doi: 10.1016/j.pmedr.2022.101954
pii: S2211-3355(22)00261-3
pmc: PMC9502666
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101954

Informations de copyright

© 2022 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

JAMA. 2018 Nov 13;320(18):1910-1928
pubmed: 30422198
Cochrane Database Syst Rev. 2016 Mar 02;3:CD008274
pubmed: 26934541
Lancet Public Health. 2017 Feb;2(2):e108-e120
pubmed: 29253389
Addict Sci Clin Pract. 2019 Oct 15;14(1):39
pubmed: 31615549
Cochrane Database Syst Rev. 2018 Feb 24;2:CD004148
pubmed: 29476653
Alcohol Alcohol. 2013 Jul-Aug;48(4):509-13
pubmed: 23531718
Circulation. 2016 Aug 9;134(6):441-50
pubmed: 27502908
J Public Health (Oxf). 2011 Sep;33(3):412-21
pubmed: 21169370
Addiction. 2009 Dec;104(12):1981-90
pubmed: 19804464
Alcohol Alcohol. 2019 Jul 1;54(4):417-427
pubmed: 31062859
Diabetes Care. 2009 Nov;32(11):2123-32
pubmed: 19875607
BMC Fam Pract. 2016 Sep 08;17(1):130
pubmed: 27608770
Lancet. 2020 Oct 17;396(10258):1223-1249
pubmed: 33069327
J Am Heart Assoc. 2018 Jun 27;7(13):
pubmed: 29950485
J Health Commun. 2016;21 Suppl 1:43-50
pubmed: 27043757
Mayo Clin Proc. 2014 Mar;89(3):382-93
pubmed: 24582196
NPJ Digit Med. 2021 Jul 22;4(1):114
pubmed: 34294852
BMC Med. 2017 Sep 28;15(1):173
pubmed: 28954635
Alcohol Alcohol. 2017 Sep 01;52(5):572-579
pubmed: 28541449
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Implement Sci. 2017 Feb 28;12(1):27
pubmed: 28241770
BMC Public Health. 2010 May 18;10:258
pubmed: 20482788
Implement Sci. 2021 Nov 20;16(1):99
pubmed: 34801041
Lancet. 2019 Jun 22;393(10190):2493-2502
pubmed: 31076174
Prev Sci. 2016 Aug;17(6):689-99
pubmed: 27167074
BMC Health Serv Res. 2018 Mar 27;18(1):208
pubmed: 29580237
Lancet. 2017 Jan 7;389(10064):37-55
pubmed: 27863813
Circ Cardiovasc Qual Outcomes. 2020 Sep;13(9):e007031
pubmed: 32885681
J Med Internet Res. 2022 Mar 23;24(3):e28927
pubmed: 35319472
Int J Drug Policy. 2020 Sep;83:102856
pubmed: 32711336
J Clin Hypertens (Greenwich). 2012 Nov;14(11):792-8
pubmed: 23126352
Addict Sci Clin Pract. 2020 May 7;15(1):17
pubmed: 32381062

Auteurs

Julia M Lemp (JM)

Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.

Supa Pengpid (S)

ASEAN Institute for Health Development, Mahidol University, Salaya, Phutthamonthon, Nakhon Pathom, Thailand.
Department of Research Administration and Development, University of Limpopo, Turfloop, South Africa.

Doungjai Buntup (D)

ASEAN Institute for Health Development, Mahidol University, Salaya, Phutthamonthon, Nakhon Pathom, Thailand.

Till W Bärnighausen (TW)

Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Harvard Center for Population and Development Studies, Cambridge, MA, USA.
Africa Health Research Institute (AHRI), KwaZulu-Natal, South Africa.

Pascal Geldsetzer (P)

Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Chan Zuckerberg Biohub, San Francisco, CA, USA.

Karl Peltzer (K)

Department of Research Administration and Development, University of Limpopo, Turfloop, South Africa.
Department of Psychology, College of Medical and Health Science, Asia University, Taichung, Taiwan.

Jürgen Rehm (J)

Institute of Clinical Psychology and Psychotherapy, TU Dresden, Dresden, Germany.
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

Bundit Sornpaisarn (B)

Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
Faculty of Public Health, Mahidol University, Ratchathewi, Bangkok, Thailand.

Charlotte Probst (C)

Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.
Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Classifications MeSH